This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BI-505

BioInvent International AB

Drug Names(s): BI-505

Description: BI-505 is a fully human antibody derived from BioInvent's proprietary n-CoDeR library. The antibody binds to the adhesion protein ICAM-1 (CD54) whose levels are elevated in tumor cells. In addition to inducing apoptosis the antibody also stimulates the immune system to eliminate tumor cells through antibody dependent cell-mediated cytotoxicity.


BI-505 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug